Tech Company Financing Transactions

TetraPhase Pharmaceuticals Funding Round

On 6/1/2010, TetraPhase Pharmaceuticals announced $45 million in Series C funding from Excel Venture Management, F-Prime Capital and Flagship Pioneering.

Transaction Overview

Company Name
TetraPhase Pharmaceuticals
Announced On
6/1/2010
Transaction Type
Venture Equity
Amount
$45,000,000
Round
Series C
Investors

Excel Venture Management (Lead Investor) (Steven Gullans)

F-Prime Capital (Robert Weisskoff)

Flagship Pioneering (Douglas Cole)

Mediphase Venture Partners (Lawrence Miller)

Presidio Partners (Karl Handelsman)

Skyline Ventures (Eric Gordon)

Proceeds Purpose
Proceeds from the Series C financing will be used to advance Tetraphase's pipeline of novel antibiotics, into Phase 1 and Phase 2 clinical studies.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
480 Arsenal St. 110
Watertown, MA 02472
USA
Phone
(617) 715-3600
Website
www.tphase.com
Email Address
[email protected]
Overview
Tetraphase Pharmaceuticals is focused on the discovery and development of new tetracycline antibiotics to treat drug resistant bacterial infections.
Profile
TetraPhase Pharmaceuticals LinkedIn Company Profile
Social Media
TetraPhase Pharmaceuticals Company Twitter Account
Company News
TetraPhase Pharmaceuticals News
Facebook
TetraPhase Pharmaceuticals on Facebook
YouTube
TetraPhase Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Guy Macdonald
  Guy Macdonald LinkedIn Profile  Guy Macdonald Twitter Account  Guy Macdonald News  Guy Macdonald on Facebook
Chief Medical Officer
Larry Tsai
  Larry Tsai LinkedIn Profile  Larry Tsai Twitter Account  Larry Tsai News  Larry Tsai on Facebook
Chief Operating Officer
Larry Edwards
  Larry Edwards LinkedIn Profile  Larry Edwards Twitter Account  Larry Edwards News  Larry Edwards on Facebook
Chief Scientific Officer
Jacques Dumas
  Jacques Dumas LinkedIn Profile  Jacques Dumas Twitter Account  Jacques Dumas News  Jacques Dumas on Facebook
VP - Finance
Christopher Watt
  Christopher Watt LinkedIn Profile  Christopher Watt Twitter Account  Christopher Watt News  Christopher Watt on Facebook
VP - General Counsel
Maria Stahl
  Maria Stahl LinkedIn Profile  Maria Stahl Twitter Account  Maria Stahl News  Maria Stahl on Facebook

 

 

Browse more venture capital transactions:

Prev: 6/1/2010: Follica venture capital transaction
Next: 6/1/2010: Giiv venture capital transaction

 

Share this article

 

Where The Data Comes From

We report on funding rounds that are announced publicly. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.